M. S. Seshadri
Christian Medical College & Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M. S. Seshadri.
Anz Journal of Surgery | 2006
Jubbin Jagan Jacob; Mathew John; Nihal Thomas; Ashok Chacko; Rekha Cherian; Ben Selvan; Aravindan Nair; M. S. Seshadri
Background: The association between pancreatic disease and primary hyperparathyroidism (PHPT) is controversial. We attempt to suggest a causal correlation and characterize the nature of pancreatic disease in PHPT.
Endocrine Practice | 2008
Thomas Vizhalil Paul; Nihal Thomas; M. S. Seshadri; Regi Oommen; Arun Jose; Narayana Mahendri
OBJECTIVE To assess the prevalence of osteoporosis in healthy ambulatory postmenopausal Indian women as measured by dual-energy x-ray absorptiometry and to study the dietary calcium intake and vitamin D status and their influence on bone mineral density (BMD). METHODS We conducted a community-based cross-sectional study in a semiurban region. A randomized cluster sampling technique was used. The study cohort consisted of 150 ambulatory postmenopausal women (> or = 50 years old). Dual-energy x-ray absorptiometry for BMD was performed at the lumbar spine and femoral neck. Dietary calcium intake and biochemical variables were assessed. RESULTS The prevalence of osteoporosis was 48% at the lumbar spine, 16.7% at the femoral neck, and 50% at any site. The mean dietary calcium intake was much lower than the recommended intake for this age-group. There was a significant positive correlation between body mass index and BMD at the lumbar spine and the femoral neck (r = 0.4; P = .0001). BMD at the femoral neck was significantly less (mean, 0.657 versus 0.694 g/cm(2)) in the vitamin D-insufficient study subjects in comparison with the vitamin D-sufficient women (P = .03). CONCLUSION The high prevalence of osteoporosis and vitamin D insufficiency in this semiurban group of postmenopausal women in India is a major health concern. Measures such as adequate calcium intake and vitamin D supplementation in women of this age-group may be beneficial.
International Journal of Diabetes in Developing Countries | 2006
Senthil K. Vasan; Nihal Thomas; Mohammed Ameen; Sunil Abraham; Beulah John; Rajani Karol; M. L. Kavitha; Kurian Thomas; M. S. Seshadri
AIM: Hypoglycemia in fasting subjects with diabetes pioglitazone arm were a mean weight gain of 3.02 kg during Ramadan is a problem that demands attention. (P=0.001) and ankle edema in 16 subjects (P=0.0002). We aimed to assess the efficacy and cost-effectiveness Direct cost per month per subject in the pioglitazone of pioglitazone on subjects fasting during the Ramadan group was INR 780.62 (US
Oral and Maxillofacial Surgery | 2008
Felix K Jebasingh; Jubbin Jagan Jacob; Apoorva Shah; Thomas Vizhalil Paul; M. S. Seshadri
17.36) vs INR 1232.50 period and to determine its role in improving the (US
Anz Journal of Surgery | 2007
Philip Finny; Jubbin Jagan Jacob; Nihal Thomas; Jim Philip; Simon Rajarathnam; Regi Oommen; Aravindan Nair; M. S. Seshadri
27.41) in the placebo group (P=0.02). glycemic control and reducing hypoglycemic episodes CONCLUSION: Pioglitazone is safe and efficacious when used as an adjunctive form of therapy for subj cts in lowering blood glucose in fasting subjects during with type 2 diabetes mellitus. Ramadan in combination with other OHAs. There is METHODOLOGY: This multicenter, double-blind no reduction in the number of hypoglycemic events randomized controlled trial included 86 fasting Muslim when compared with conventional therapy without subjects with type 2 diabetes mellitus. The study was pioglitazone. There is a significant cost benefit when initiated 74 days prior to Ramadan to optimize pioglitazone is added to other OHAs in this study. glycemic control. The subjects were randomized to 30 mg of pioglitazone once daily and placebo in
Endocrine Practice | 2011
Krishna Sudeep; Ashok Chacko; Nihal Thomas; Ratnasamy Selvakumar; Biju George; Thomas Vizhalil Paul; M. S. Seshadri
IntroductionSymptomatic skeletal disease in primary hyperparathyroidism is over 30 times more common in India compared to the west. The classical “brown tumour” is commonly seen with the major sites being ends of long bones, the pelvis and ribs. Facial involvement is rare and, when present, usually involves the mandible.Case reportWe report a 68-year-old gentleman with a rare initial presentation of primary hyperparathyroidism with bilateral maxillary brown tumours.Discussion and conclusionSuccessful parathyroid surgery resulted in a regression in the tumours. The report highlights the need to consider primary hyperparathyroidism in the initial differential diagnosis of bony lesions of the jaw.
PLOS ONE | 2013
Anulekha John; George Priya Doss C; Andrew Ebenazer; M. S. Seshadri; Aravindan Nair; Simon Rajaratnam; Rekha Pai
Background: Management of medullary thyroid carcinoma (MTC) remains controversial despite many advances over the past five decades. We attempt to review the presentation, management and prognosis of MTC at our institution over the last two decades.
Journal of Osteoporosis | 2014
Sahana Shetty; Nitin Kapoor; Dukhabandhu Naik; Hesarghatta Shyamasunder Asha; Suresh Prabu; Nihal Thomas; M. S. Seshadri; Thomas Vizhalil Paul
OBJECTIVE To study bone mineral content (BMC), bone mineral density (BMD), vitamin D status, and bone mineral variables in patients with chronic nonalcoholic pancreatitis and to determine the relationship between pancreatic dysfunction and these variables. METHODS Thirty-one eligible nonalcoholic men with proven chronic pancreatitis and 35 male control subjects were studied. Biochemical data, variables of malabsorption, and BMD of the lumbar spine were evaluated. RESULTS In patients with chronic pancreatitis, the mean body mass index (BMI) was 18.46 kg/m² and the median 25-hydroxyvitamin D value was 15.5 (range, 5.0 to 52.0) ng/mL. A T-score of less than -2.5 was found in a higher proportion of study patients (9 of 31, 29%) than of control subjects (3 of 35, 9%). BMI correlated significantly with BMC (r = 0.426; P = .017). There was an inverse correlation between stool fat and BMC (r = -0.47; P = .03) in patients with chronic pancreatitis and steatorrhea. There was no significant correlation between serum 25-hydroxyvitamin D or biochemical variables and BMD. Patients with steatorrhea had a significantly lower BMC than did those without steatorrhea, and this difference could not be accounted for by differences in BMI, presence of diabetes, or hypovitaminosis D. CONCLUSION Pancreatic osteodystrophy is a novel entity consisting of osteopenia, osteoporosis, and osteomalacia in patients with chronic pancreatitis. The inverse correlation between stool fat and BMC in patients with chronic pancreatitis, the strong positive correlation between BMI and BMC, and the lack of difference in BMC between subjects with vitamin D sufficiency and those with vitamin D deficiency suggest that long-standing malabsorption with attendant chronic undernutrition is the major factor contributing to the changes in BMC.
Indian Journal of Endocrinology and Metabolism | 2013
Kishore Kumar Behera; Nitin Kapoor; M. S. Seshadri; Simon Rajaratnam
Various missense mutations in the VHL gene have been reported among patients with familial bilateral pheochromocytoma. However, the p.Arg82Leu mutation in the VHL gene described here among patients with familial bilateral pheochromocytoma, has never been reported previously in a germline configuration. Interestingly, long-term follow-up of these patients indicated that the mutation might have had little impact on the normal function of the VHL gene, since all of them have remained asymptomatic. We further attempted to correlate this information with the results obtained by in silico analysis of this mutation using SIFT, PhD-SNP SVM profile, MutPred, PolyPhen2, and SNPs&GO prediction tools. To gain, new mechanistic insight into the structural effect, we mapped the mutation on to 3D structure (PDB ID 1LM8). Further, we analyzed the structural level changes in time scale level with respect to native and mutant protein complexes by using 12 ns molecular dynamics simulation method. Though these methods predict the mutation to have a pathogenic potential, it remains to be seen if these patients will eventually develop symptomatic disease.
Journal of Diabetes | 2012
Senthil K. Vasan; Alicia E.I. Pittard; Joison Abraham; Prasanna Samuel; M. S. Seshadri; Nihal Thomas
Objective. To study the prevalence of osteoporosis and vitamin D deficiency in healthy men and to explore the influence of various life style factors on bone mineral density (BMD) and also to look at number of subjects warranting treatment. Methods. Ambulatory south Indian men aged above 50 were recruited by cluster random sampling. The physical activity, risk factors in the FRAX tool, BMD, vitamin D, and PTH were assessed. The number of people needing treatment was calculated, which included subjects with osteoporosis and osteopenia with 10-year probability of major osteoporotic fracture >20 percent and hip fracture >3 percent in FRAX India. Results. A total of 252 men with a mean age of 58 years were studied. The prevalence of osteoporosis and osteopenia at any one site was 20% (50/252) and 58%, respectively. Vitamin D deficiency (<20 ng/dL) was seen in 53%. On multiple logistic regression, BMI (OR 0.3; P value = 0.04) and physical activity (OR 0.4; P value < 0.001) had protective effect on BMD. Twenty-five percent warranted treatment. Conclusions. A significantly large proportion of south Indian men had osteoporosis and vitamin D deficiency. Further interventional studies are needed to look at reduction in end points like fractures in these subjects.